Firm Profile > Goodwin > Washington DC, United States
901 NEW YORK AVENUE, NW
WASHINGTON DC 20001
Goodwin > The Legal 500 Rankings
Goodwin's 'team has the depth and breadth to assess and address the complex issues of REIT structuring, operations and qualifications'. It advises both public and private REITs and real estate investment bankers on equity and debt offerings for existing clients, IPOs, M&A transactions and complex joint venture investments. Key clients include LaSalle Hotel Properties, Boston Properties, Brookfield Financial Properties, Gaming & Leisure Properties, Medical Properties Trust and Prologis. The practice acted for LaSalle Hotel Properties, a multi-operator REIT that owns, redevelops and repositions upscale hotels, in its merger agreement with Pebblebrook Hotel Trust; and advised Medical Properties Trust on its high-value joint venture agreement with Primonial Group. It also assisted Gaming and Leisure Properties, a REIT specializing in casino properties, with its simultaneously entering into purchase and sale agreements, and new and amended master leases. Gilbert Menna and Ettore Santucci, who divide their time between Boston and New York, co-chair the firm’s REITs and real estate M&A practice; also highly regarded are New York partner Yoel Kranz and Boston's Marc Lazar.
Technology transactions Tier 1
Goodwin handles M&A involving complex licensing, patent and software issues, and also has expertise in standalone commercial transactions including software leasing agreements and technology development contracts. Pre-empting a planned public offering, the firm advised software company Qualtrics on its $8bn acquisition by SAP. John J. Egan acted for internet software company AppNexus in the negotiation of an agreement to join AT&T’s advertising and analytics platform. Further, the firm advised software company Kensho Technologies on its sale to S&P Global for an aggregate purchase price of $550m. Other key figures include joint practice heads Kenneth J. Gordon and Silicon Valley-based Anthony J. McCusker, Stephen G. Charkoudian, and Robert E. Bishop and Robert G. Kester, who are rated for their ability to ‘drive a deal to a successful close’. Jon M. Novotny and Joshua Cook joined the San Francisco office from Gunderson Dettmer LLP in October 2018, while Washington DC-based Julie K. Tibbets joined from Alston & Bird LLP in February 2018. Named lawyers are based in Boston unless stated otherwise.
The ‘exceptionally knowledgeable group’ at Goodwin is variously lauded as ‘a dominant player in technology transactions’, ‘a leader in the REITs space’ and also ‘strong in life sciences’. The firm’s issuer-side practice had a banner year, which included several flagship IPOs, and also continued to attract high-profile mandates from managers. Among the names to note, California capital markets chair Richard Kline is ‘a powerful force in technology deals’. Kline, who splits his time between Silicon Valley and San Francisco, paired up with Boston-based James Barri (‘among the best in the business’) to advise Guidewire on its $200m offering of common stock and concurrent $360m offering of convertible senior notes. In a headline IPO, a Boston-based team co-led by Stuart Cable, Arthur McGivern and Sarah Ashfaq assisted Rubius Therapeutics with its $277.3m upsized IPO. On the manager side, Boston-based Robert Puopolo and New York-based Seo Salimi advised the underwriters on Arvinas’ $120m IPO.
With expertise in industry sectors ranging from life sciences to real estate, Goodwin handles a steady flow of commercial transactions including IP licensing, tech commercialization and technology transfers. Jointly headed in the Boston office by Lisa R. Haddad, John T. Haggerty and Deborah S. Birnbach, the team recently advised Bluebird Bio on its strategic collaboration with Gritstone Oncology to research, develop and commercialize cancer treatment products. Also of note, the team acted for Galapagos and MorphoSys in their global licensing agreement with Novartis Pharma to cover the commercialization and joint development of the monoclonal antibody MOR106. In 2018, Jon M. Novotny and Joshua Cook joined the San Francisco office from Gunderson Dettmer LLP, and the practice group also brought on several new lawyers from Dechert LLP and Fenwick & West LLP. New York-based Jane Greyf joined Latham & Watkins LLP, and Caitlin Murray also left the practice group.
As ‘one of the most responsive and attentive data security law firms’, Goodwin is experienced in data breaches and incident response, regulatory investigations, litigation, transactions and M&A, and advice on GDPR. Practice head Brenda Sharton ‘has been advising clients since the early days of data security and privacy’. Highlights include assisting cloud-based identity and access management provider OneLogin with a data breach in which an unauthorized user gained access to the client’s US database, and acting for several businesses in consumer class actions, government investigations and enforcement actions alleging violations of the Telephone Consumer Protection Act (TCPA). Washington-DC based Karen Neuman and the ‘very notable’ David Kantrowitz, who was made counsel in January 2019, are other key contacts. Named individuals are based in Boston unless otherwise indicated.
ERISA litigation Tier 2
According to one client, the team at Goodwin is 'among the best in the business’. Headed by Boston-based James Fleckner ('the gold standard in the field'), the team is involved in a number of significant matters including defending American Century, FirstGroup America, General Electric, and various others, in numerous 401(k) breach claims. The team is also representing Newport Trust Company in stock-drop litigation with claims for over $800m in damages. Other key contacts include 'expert' partner Alison Douglass, Jack Cleary, and New York-based Gabrielle Gould and Sam Rubin.
Fintech Tier 2
The notable breadth of the interdisciplinary fintech practice at Goodwin spans alternative lending, bank charters and partnerships, digital currency and blockchain technology, insurtech, payments and wealth management matters. Silicon Valley-based Grant Fondo is leading a team representing Tezos Foundation in state and federal securities class actions related to the launch of its blockchain platform. A team also acted for Coinbase in litigation, and successfully limited the scope of US Internal Revenue Service's attempt to use a 'John Doe' summons to obtain records for all account holders. The group's non-contentious experience includes advising Circle Internet Financial, a mobile-payments company, on its acquisition of Poloniex, a leading token exchange and cryptocurrency trading platform, and the formation of crypto-asset funds, Electric Capital Partners and Scalar Capital Management. Washington DC-based counsel David Solander and private investment fund partner Ian O’Donnell in San Francisco jointly lead a team which acts as lead fund and management counsel for Meta Stable and advised the client on restructuring planning and compliance matters. Other key names to note include head of the alternative lending and payments group, Mike Whalen, who is based in Washington DC and Mitzi Chang in San Francisco, who jointly leads the digital currency and blockchain technology practice alongside Fondo. Recent additions to the team include Scott Joachim, who splits his time between the Silicon Valley and New York offices, and David Johanson and Tamira Goldberg who are based in Silicon Valley and New York respectively, and all joined from Fenwick & West LLP.
Land use/zoning Tier 2
The lawyers at Goodwin are ‘reliable, thorough, calm and composed, and highly professional’. A fixture in the Massachusetts market, the practice group advises across the spectrum of complex land use and zoning mandates, including site acquisition and due diligence, zoning and subdivision control, environmental permitting, historic preservation, cost recovery and liability management, as well as a litany of related corporate deals. In particular, the firm has a track record of working on landmark projects in Boston, an example of which involved acting for Boston Properties in a joint venture with Delaware North for the development, permitting and leasing of an air rights parcel comprising a portion of The Hub on Causeway, including permitting for the third tower. The team has also been acting for Meredith Management in the development of the Fenway Center, a multi-building mixed-use project. A key figure in the team is practice head Martin Healy, ‘an outstanding leader’, who is ‘responsive, personable and able to quickly focus on the important issues and articulate his advice practically and without legal jargon’. Also recommended is of counsel Lawrence Kaplan, who is assisting longstanding client New Balance with several matters, including its multi-phased, mixed-use redevelopment of a 22-acre campus in Brighton. Other lawyers of note are counsel Robert Fitzgerald and senior associate Jennifer Schultz. All named practitioners are based in Boston.
Goodwin has extensive experience advising buyers and sellers on high-value and high-profile corporate and M&A transactions, and the practice has sector expertise in technology, life sciences, REITs and financial institutions, as well as private equity buyouts; it also handles hostile M&A deals. Significant clients are AMAG Pharmaceuticals, AppNexus, Fresenius Medical Care North America, Centerview Partners and Brookfield Properties. Stuart Cable, who currently serves as the chair of the M&A and corporate finance practices for the technology and life sciences business units, is 'a truly outstanding expert in navigating complex deals through the various gates and is able to balance sometimes quixotic legal requirements with practical solutions'; and John Egan III acted for AppNexus, a global internet technology company, in its definitive agreement to be acquired by American multinational conglomerate AT&T. Other significant highlights included the team advising the independent transaction committee of the board of directors of Sprint on its merger with wireless network operator T-Mobile US; and acting for sports uniform retailer Varsity Brands Holding on its sale to Bain Capital Private Equity. Lisa Haddad, who is particularly focused on public company M&A, corporate and securities expert John Haggerty and Deborah Birnbach, whose clients include healthcare, life sciences, technology and financial services companies, jointly chair the firm’s public M&A and corporate governance practice. Also highly rated are joint REITs and real estate M&A chair Gil Menna, David Cappillo, Michael Patrone and Jared Fine; Scott Joachim was hired for the Silicon Valley and New York offices from Fenwick & West LLP. Named advisers are in Boston unless otherwise stated.
Product liability, mass tort and class actions: consumer products (including tobacco) - defense Tier 2
Led by Joanne Gray, Goodwin’s product liability and mass tort practice has a strong focus on the food and beverages industry, where it frequently advises clients on regulatory, compliance and risk management matters, in addition to recalls and product liability litigation. Acting alongside Glenn Kerner, Gray continues to represent longstanding client Herbalife in all product liability cases, including the Ephedra MDL, while Richard Oetheimer in Boston is defending cosmetic products manufacturer Kolmar Laboratories in talc mass tort litigation involving asbestos exposure claims. Counsel Forrest Hainline and Nilda Isidro are other key names of the practice. The department's client roster also includes Danone, Daily Harvest and KIND. All partners are based in New York unless otherwise stated.
Real estate Tier 2
Goodwin handles acquisitions and dispositions, development, design, construction and leasing matters, with a particular focus on the leisure and hospitality industry. Other areas of expertise include joint ventures, alternative capitalization strategies, and fund structuring and formation for sponsors and managers. Andrew Sucoff recently advised Brookfield Financial Properties on its $15.3bn acquisition of the remaining 66% of GGP not already owned by Brookfield and its affiliates. Another highlight included acting for Boston Properties on a joint venture with Canada Pension Plan Investment Board which included the acquisition of a leasehold of an office campus in Santa Monica with an aggregate value of $661m. Team head Minta Kay advised GreenOak Real Estate Advisors on the formation of a joint venture with a subsidiary of The Glick Family Office to to acquire 1200 New Hampshire in Washington DC; this involved mortgage and mezzanine financing of $150m. A further recent highlight included the representation of Cabot Industrial Value Fund IV, a closed private equity fund, on the sale of a $1.8bn industrial portfolio to Blackstone Real Estate Income Trust. Samuel Richardson specializes in financing, acquisitions, dispositions, joint ventures and also deals with restructuring debt and equity investments. Gilbert Menna is also recommended. Diana Brummer joined as partner in New York from Stroock & Stroock & Lavan LLP. All named attorneys are based in Boston unless otherwise stated.
Shareholder activism Tier 2
At Goodwin, Joseph Johnson and Andrew Goodman in Boston acted for Monotype Imaging Holdings in its successful defense of a threat of a proxy campaign brought by Starboard Value, which resulted in the activist fund withdrawing its board nominees without a settlement agreement. The pair also advised Cedar Realty Trust on defending a campaign brought by Snow Park Capital Partners. Also recommended is Joseph Theis, who, acting alongside Goodman and Johnson, successfully defended Brightcove, in a proposed proxy contest brought by Tenzing Global.
With offices in Boston, Washington DC, New York, Los Angeles and the Bay Area, Goodwin has a wide-ranging, bicoastal practice, which has an excellent reputation for its strength in the life sciences sector; tech is a supplementary area of expertise. The team represented online pharmacy PillPack in its high-profile acquisition by Amazon, and assisted Kensho Technologies with its $550m sale to S&P Global. It also advised Slack Technologies on its $427m Series H financing. Mitchell Bloom and Kingsley Taft, both based in Boston, share leadership of the life sciences team, while John Egan, Anthony McCusker in Silicon Valley, and Kenneth Gordon lead the technology practice. Boston-based Bill Schnoor, who advises robotics company Superpedestrian, is another key contact. Jonathan Axelrad has retired.
Appellate Tier 3
Goodwin’s team has ‘a truly in-depth understanding of appellate law and a close familiarity with the procedures applicable at the courts of appeals’. Practice co-chair William Jay attracts commendation from clients for his ability to ‘cut to the chase and articulate clear arguments’, as well as for being ‘one of the very few appellate attorneys who have mastered the intersection between technology, patent law and appellate procedures’. Jay and recently promoted partner David Zimmer (Boston) secured a victory for petitioner Wescley Pereira at the US Supreme Court, which sided with Pereira in adopting an immigrant-friendly interpretation of the removal provisions under the Immigration and Nationality Act. In another highlight at the US Supreme Court, the trio of Jay, co-chair Kevin Martin and Brian Burgess led the team on representing the Puget Sound Indian Tribes as respondents in Washington v United States, a case involving the interpretation of a set of historic treaties protecting the tribes’ fishing rights.
Corporate governance Tier 3
The team at Goodwin has particular expertise in acting for special committees. Stuart Cable and Mark Opper advised the independent transaction committee of the board of Sprint on its merger with T-Mobile, and Cable and Lisa Haddad also advised a special committee of the board of Foundation Medicine on the company's merger with Roche. Joseph Johnson and Andrew Goodman and Gilbert Menna in New York acted for Lasalle Hotel Properties, which was sold to Pebblebrook Hotel Trust in a hostile deal following involvement from activist investors. Other key contacts include John Egan and Michael Minahan. Named lawyers are based in Boston unless otherwise noted.
Environment: litigation Tier 3
The 13-strong team at Goodwin acts on matters related to contaminated sediment sites and Superfund sites, hard rock mining, natural resources damages and other environmental enforcement proceedings and settlements. The firm continues to counsel Morton International (a subsidiary of key client Dow Chemical) in relation to the Berry’s Creek Study Area Superfund site in New Jersey, as well as in the Passaic River litigation. Practice head Laurence Kirsch leads the cases with support from Michael Giannotto; both are based in Washington DC. Elise Zoli left for Jones Day and Gregory Bibler left to set up his own firm.
Environment: regulatory Tier 3
Goodwin is instructed in matters involving contaminated sediment sites, hardrock mining, Superfund mega sites, natural resource damage claims, multi-media environmental enforcement proceedings and settlements, vapour intrusion problems, and complex compliance settlements. The group continues to act as regular outside counsel to longstanding client Newmont Mining in relation to environmental, public lands, and energy matters, including representing the client before the EPA, the Office of Management and Budget, and the DOI in connection with the EPA’s initiative to promulgate financial responsibility requirements for the hardrock mining industry under CERCLA. Additionally, the team advises on legislation related to the management of mercury generated as a by-product of gold mining, and also works with industry and environmental groups and Congressional staffers to develop “Good Samaritan” legislation that would relax liabilities and requirements imposed by the federal environmental laws on mining companies that voluntarily remediate sites polluted in the past by third parties. Contacts in Washington DC include Michael Giannotto and William Jay. Elise Zoli joined Jones Day, Gregory Bibler left to set up his own firm, and Laurence Kirsch moved to Sidley Austin LLP in March 2019.
With significant strength in depth across the firm's offices in New York, Washington DC, Boston and California, the 'strategic and knowledgeable' team at Goodwin is well positioned to handle a variety of financial services agency investigations and related private litigation, regardless of geographical location. The firm remains 'very active in the consumer finance space', an area in which 'outstanding' Washington DC-based partner Thomas Hefferon is a key practitioner and frequently leads on the most substantial mandates. Hefferon's recent highlights include his continued defense of Bank of America in a series of actions brought by various municipalities alleging that the bank engaged in discriminatory lending. New York-based Marshall Fishman has a strong track record in credit crisis-related disputes, including litigation involving complex structured products; he is currently representing BNP Paribas as one of the defendants accused of manipulating the market for interest rate swaps. California litigation leader Grant Fondo is well versed in many of the new emerging technologies within the financial services sector, including as it relates to blockchain and cryptocurrencies; alongside Los Angeles-based Steven Ellis, Fondo is acting for Coinbase in responding to an attempt by the IRS to obtain, through a 'John Doe' summons, transaction records relating to all of Coinbase’s account holders for a three-year period. 'Top-notch' Boston-based partner Jim McGarry is noted for his 'superb written product', particularly in the context of consumer finance disputes.
Healthcare: life sciences Tier 3
Goodwin 's Boston-based practice co-head Mitchell Bloom, who specializes in venture capital firms and investment banks focused on life sciences, recently assisted Ablynx with its €3.9bn agreement to be acquired by Sanofi, and advised California-based biopharmaceutical company Eidos on its $106m initial public offering. Co-head Kingsley Taft (also based in Boston) advised long-standing client Moderna on a $500m equity financing round. Surface Oncology and Zagfen are other notable clients. New-York-based Elizabeth Holland is well versed in Hatch-Waxman litigation, while Washington DC’s Julie Tibbets, who joined from Alston & Bird LLP in February 2018, focuses on FDA regulatory work. Other key arrivals in 2018 include New York-based Jonathan Schur and Kristopher Brown from Dechert LLP, San Francisco’s IP litigator Darryl Woo from Vinson & Elkins LLP and Silicon Valley’s Shane Albright from DLA Piper LLP (US). Boston’s Chad Davis moved to Dechert LLP.
M&A litigation: defense Tier 3
Goodwin handles deal-related litigation in state and federal courts throughout the US, often acting for the sellers in cases involving life sciences, technology, real estate and financial services companies. Deborah Birnbach is the standout practitioner in Boston following the retirement of Stephen Poss. She is currently awaiting a decision on a motion to dismiss in a case challenging her client NeuStar's $2.9bn merger with affiliates of Golden Gate Private Equity, which centers on allegations that the company made misleading statements about the transition of a key government contract to a new service provider. She also won a fiduciary duty case in Maryland State Court, which enabled LaSalle Hotel Properties to proceed with a $5.2bn merger. Michael Jones is an up-and-coming partner in Menlo Park and he defended DCT Industrial Trust in three shareholder disputes challenging its $4.8bn merger with Prologis. Also recommended are Adam Slutsky in Boston and, in New York, Marshall Fishman and Gabrielle Gould.
Merger control Tier 3
The 'lean team' at Goodwin 'punches above its weight' and 'has substantial agency experience'. The 'top-notch practical, effective and efficient' lawyers 'routinely handle high-profile and complex transactions across a good number of industry sectors' under the leadership of 'real star' Andrea Murino and Christopher Holding in Washington DC. The independent directors of Sprint recently appointed a team of Murino and 'impressive merger practitioner' Paul Jin - who recently joined from Wilson Sonsini Goodrich & Rosati - to advise on its merger with T-Mobile. In other highlights, the group is representing a number of individual healthcare providers in their efforts to merge and form the second-largest healthcare system in Eastern Massachusetts. In Boston, counsel Kirby Lewis is a key name to note.
The team at Goodwin has particular expertise in acting for independent trustee boards. Marco Adelfio ('an engaged, proactive, and a strong communicator') and Paul Delligatti continue to advise the independent trustees of the Eaton Vance funds, most recently on implementing liquidity risk management programs following new regulations issued by the SEC. Delligatti and counsel Thomas Early, based in Los Angeles, provide ongoing advice to the independent trustees of the Federated Funds, while Christopher Palmer is instructed by Prudential Insurance Funds, with $210bn under management. Robert Kurucza is another key contact. Philip Newman retired in 2018. The team is based in Washington DC unless stated otherwise.
Patents: licensing Tier 3
Goodwin primarily acts for technology and life sciences clients, both domestic and international. Due diligence in the context of mergers and acquisitions, financings and public offerings are as much part of the team's experience as stand-alone technology transactions, including strategic alliances and collaboration agreements. A recent standout instruction saw Stephen Charkoudian, who jointly heads the practice in Boston with Kingsley Taft, advise Kind on its strategic partnership with Mars. Former DLA Piper LLP (US) practitioner Shane Albright joined in Silicon Valley, while Jonathan Schur joined the New York team from Dechert LLP. Noelle Dubiansky in Washington DC and Bethany Withers in Boston made partner. Other clients include Aerpio Pharmaceuticals, Crispr Therapeutics and WiTricity.
Goodwin impresses with 'experienced, savvy, solutions-oriented counsel' that is 'responsive' and 'creative'. Especially adept at litigation concerning pharmaceuticals and biosimilars, the group also has expertise in technology-related mandates. In a recent highlight, Washington DC's William Jay is representing respondent Teva Pharmaceutical in a Supreme Court case against Helsinn involving the interpretation of a stipulation in the America Invents Act regarding the sale of inventions under a confidentiality agreement. Additionally, the practice won two district court cases for Dr. Reddy's Laboratories against Reckitt Benckiser and MonoSol X, concerning a generic version of opioid use disorder drug Suboxone that the client sought to launch. Actavis Laboratories, Facebook and Gillette also feature on the client roster. New York's Mark Abate and 'first-rate strategic thinker' Elaine Blais in Boston are key contacts. Trio Ronald Pabis, Stephen Shahida and Patrick McCarthy in Washington DC, who joined from Greenberg Traurig LLP alongside Mark Davis, 'are an incredible team'. Darryl Woo joined the San Francisco office from Vinson & Elkins LLP. Marcia Sundeen and Marta Gross retired. Counsel Brian Robinson left for Novartis.
Goodwin's 'responsive and reliable' team has solid expertise advising sponsor-side clients on fund formation mandates, with venture capital and real estate funds making up a large part of the group's workload. In the Boston office, David Watson is advising Turner Impact Capital on forming Healthcare Facilities Fund, with a $250m target, which will develop healthcare facilities in under-served communities. Watson and Matthew Giles assisted LBA Realty with establishing its sixth fund, LBA Realty Fund VI, which closed with commitments of $900m. Thomas Beaudoin and James Donohue are other names of note in Boston. In Washington DC, Paul Verbesey assisted Charlesbank with forming Charlesbank Equity Fund IX, a $2.75bn private equity fund, and also handled the $675m Charlesbank Fund IX Overage Program, a co-investment vehicle. San Francisco-based Ian O’Donnell specializes in venture capital work. Verbesey and New York-based John Ferguson share leadership of the practice. Jonathan Axelrad has retired.
Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense Tier 3
The product liability and mass tort litigation practice at Goodwin is headed by Joanne Gray in New York and focuses on trial work and risk management. A team led by New York-based Glenn Kerner is representing Teva Pharmaceuticals as national counsel in personal injury litigation relating to the cardiac drug amiodarone, which was allegedly over-prescribed and caused blindness, pulmonary toxicity, pulmonary fibrosis, kidney damage, neurotoxicity and death; Richard Oetheimer in Boston is defending the same client against plaintiffs who opted out of the national settlement relating to the metoclopramide litigation. In another highlight, Boston-based Sarah Frederick defended Boehringer Ingelheim in a wrongful death lawsuit alleging the packaging of the blood-thinning medication Praxada did not adequately warn of the risk of a fatal bleed.
The product liability and mass torts practice at Goodwin has particular expertise in chemical exposure and water contamination cases. Led by Boston-based Mark Tully, the team continues to represent Gulf Oil and Cumberland Farms in litigation, in which plaintiffs allege that the gasoline additive methyl tertiary-butyl ether is contaminating drinking water. Also in Boston, Richard Oetheimer is defending Northrop Grumman against an asbestos-related wrongful death claim. Washington DC-based William Hanlon and practice head Joanne Gray in New York are also recommended.
Clients praise the practice at Goodwin for its 'depth of knowledge in the securities litigation field, outstanding written work product, and excellent oral advocacy'. The firm climbs the ranking this year having won impressive dismissals in cases against pharmaceutical and medical device companies, including for Foundation Medicine and PTC Therapeutics. The key partners in those cases were Boston-based Deborah Birnbach (who is 'a truly excellent advocate who knows securities litigation backwards and forwards') and Caroline Bullerjahn, who is 'truly a pleasure to work with'. Mark Holland in New York and Michael Isenman in Washington DC scored precedent-setting wins for JP Morgan Investment Management in long-running excessive fees litigation. In New York, Marshall Fishman, who led market manipulation matters for Wall Street banks, and Brian Pastuszenski, who acted for underwriters in matters arising from NovoCure's IPO, are also recommended. Douglas Flaum joined the firm in 2019 from Paul Hastings LLP.
Alternative/hedge funds Tier 4
Regulatory work is a cornerstone area of expertise for Goodwin's hedge fund practice; New York-based Brynn Peltz provides ongoing advice to C-III Capital Partners and Alger Dynamic Return Fund on fund structuring, management and compliance matters. Counsel David Solander ('a real team player'), based in Washington DC, advises Multicoin Capital Management on regulatory, restructuring, compliance and financing matters regarding cryptocurrency fund investments. Other clients include Discovery Capital Management and Electric Capital Partners.
Capital markets: debt Tier 4
Goodwin, widely regarded as a ‘leader in REIT-related deals’ and a ‘powerful force in technology transactions’, has continued to consolidate its position in its key sectors. Richard Kline, who splits his time between Silicon Valley and San Francisco, chairs the California capital markets group and is a ‘technology specialist’; he acted alongside debt capital markets co-chair James Barri, ‘a fantastic lawyer’ based between Boston and New York, to advise Atlassian on its $1bn private offering of convertible senior bonds. The same team assisted Zendesk with its $575m convertible senior notes offering. The firm has also been developing an underwriter-side practice, and has recently advised banks on offerings in the REIT, technology and life sciences sectors. REITs co-chair Ettore Santucci, who works out of the Boston and New York offices, is also recommended.
In 2018, the team at Goodwin was joined by former head of the office of enforcement at the Consumer Financial Protection Bureau Anthony Alexis in Washington DC and James Gatta in New York, who served as chief of the Criminal Division in the US Attorney's Office for the Eastern District of New York. Silicon Valley's Grant Fondo and New York's Richard Strassberg are representing John Stumpf, former chairman and CEO of Wells Fargo Bank, in litigation and investigations following settlements by various agencies regarding allegations the bank opened unauthorized accounts and issued unauthorized products for customers. Boston's Jennifer Chunias and Silicon Valley's Lloyd Winawer served as lead counsel for the audit committee of Celadon Group's board of directors in connection with an internal investigation into the company's previously issued financial statements. Boston's Joseph Savage and New York's Anne Railton are other key names.
Goodwin’s practice head, Scott Webster, provides ERISA Title 1 advise to financial services organizations and fund sponsors. Retirement plan asset investments (including fiduciary, investment and prohibited transaction matters) and the establishment and operation of collective investment vehicles including VCOCs and REOCs are particular strong points. Natasha George is a key name for designing, implementing and terminating executive compensation and severance agreements, while San Francisco-based Lynda Galligan provides the full range of compensation and benefits advice to clients in the technology and life sciences sector. James Mattus also comes recommended for structuring, implementing and administering equity-based and incentive compensation plans, including providing advice with respect to tax and securities law. Rachel Smith and Sarah Bock are also names to note in the Boston-based team.
The Boston-based team at Goodwin saw considerable expansion with the promotion of Sarah Bock and the arrival of Rachel Faye Smith from Murtha Cullina LLP. Headed by Scott Webster, the team's standout matters included advising on Amplify Snack’s $1.6bn share sale to Hershey’s, and assisting Varsity Brand with its $2.5bn sale to Bain Capital. In addition, Webster and Natascha George acted for Kensho Technologies in its $686m sale to S&P Global. James Mattus is also recommended. Other key clients include Dimension Therapeutics, Frazier Healthcare and Thompson Reuters.
Private equity buyouts Tier 4
Goodwin's impressive national practice has strong teams in Boston, New York, Washington DC, Los Angeles, San Francisco and Silicon Valley. It covers a range of transactions from growth equity to large leveraged buyouts and high-value exits. The team 'does a terrific job on technology sector transactions', 'brings a winning combination' through 'deep dives into all relevant aspects of a target's business', 'attentiveness to the complexities of the deal itself and super-responsiveness under often difficult circumstances'. In 2018, it enhanced its standing in Silicon Valley through the hire of Scott Joachim and David Johanson from Fenwick & West LLP; the two add particular expertise in fintech. Real estate and healthcare are also strong sectors for the national team. Clients include TA Associates, Pamplona Capital Management, Bain Capital Ventures and JMI Equity. Boston's John LeClaire and Michael Kendall head the practice alongside Andrew Weidhaas in Los Angeles, who is 'deeply knowledgeable and skilled, but also exceptionally user friendly'. New York partner Stuart Rosenthal led the team that advised Primus Capital on its $400m sale of portfolio company Hyperwallet to PayPal. Boston partner Jon Herzog is regularly advises TA Associates, which he assisted with its acquisition of software company Flexera. New York's Chris Nugent has 'an incredible sense of urgency and desire to achieve the best outcome'. San Francisco partner Brian McPeake is also recommended.
US taxes: non-contentious Tier 5
Goodwin’s ‘very responsive’ tax group ‘uses its excellent knowledge of the new tax regulations and expansive resources to address complex situations with sovereign wealth investors’. Recent highlights included Edward Glazer in Boston and Kelsey Lemaster in San Francisco acting for DCT Industrial Trust in its $8.4bn stock-for-stock sale to Prologis. Glazer also advised Gaming and Leisure Properties on its agreement with Eldorado Resorts to purchase Tropicana Entertainment for approximately $1.9bn. New York partner William Weiss (rated for his ‘excellent, nuanced tax advice’) recently advised KIND on its sale of a minority stake to Mars, in a transaction valued at approximately $4bn. Practice chair Neal Sandford is noted for his ‘excellent skills in identifying the issues and developing tax efficient structures that meet the business and operational requirements of each client’.
Goodwin acts for major stakeholders in distressed companies on issues ranging from exclusivity and contested plan confirmation to claims allowance and inter-creditor disputes, 'considering all aspects of an issue to find the best approach'. The team of experienced negotiators and litigators works for borrowers, lenders, acquirers and committees of creditors across a variety of sectors, often in matters with cross-border aspects. The 'intelligent, energetic and committed' Michael Goldstein jointly leads the New York-based practice and is representing musical instruments manufacturer Gibson Guitar in its Chapter 11 restructuring valued at $500m in funded indebtedness. In another highlight, co-head William Weintraub is acting for Charlesbank Capital Partners and CB Marathon Opco in the purchase of the assets of Rockport Company et al resulting from Rockport's Chapter 11 proceedings. Other clients include Urban Edge Properties, Amobee and SolarWorld Americas.
Goodwin > Firm Profile
Firm overview: Goodwin’s 1,000 plus lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigation, and world-class advisory services in the financial, life sciences, private equity, real estate, and technology industries. The firm’s unique combination of deep experience serving both the innovators and the investors in a rapidly-changing, technology-driven economy sets Goodwin apart. To learn more, visit www.goodwinlaw.com and follow Goodwin on Twitter (@goodwinlaw), LinkedIn (@goodwinlaw), Facebook (@join_goodwin), and Instagram (@join_goodwin).
Main areas of practice: Complex transactions, high-stakes litigation and world class advisory services in the financial, private equity, real estate, technology and life sciences industries.
Complex transactions: A sophisticated, versatile team of transactional lawyers provides broad market perspective, serves as a business partner on strategic transactions, and advises clients on structuring and developing new and innovative products and services. Areas of expertise include buyouts and acquisitions, capital markets, debt finance, financial restructuring, growth equity, impact and responsible investing, mergers and acquisitions, new company formation, private investment funds, REITs and real estate mergers and acquisitions, search funds, tax, and venture capital.
World-class advisory services: Experienced regulatory lawyers, including many former high-ranking government officials and regulators, guide clients through the complex conundrum of government regulations with insight and ingenuity – always with an eye toward maximizing business opportunities while minimizing risk. Areas of expertise include antitrust and competition, banking, environmental, ERISA and executive compensation, FDA, FinTech, global trade, investment management, labor and employment, and privacy and cybersecurity.
High-stakes litigation: Goodwin litigators provide cost-effective, results-oriented representation in high-profile matters across the United States. The firm employs a holistic, cross-disciplinary approach, helping clients settle disputes, mitigate risk, defend their interests, and, in most cases, avoid trial altogether. Areas of expertise include appellate, business and commercial, government investigations and enforcement, environmental, financial industry, intellectual property, labor and employ-ment, privacy and cybersecurity, products liability and mass torts, securities, trade secrets and restrictive covenants, and white collar defense.
|Mr Marco Adelfio||View Profile|
|Mr Anthony Alexis||View Profile|
|Mr Brian Burgess||View Profile|
|Mr Mark Davis||View Profile|
|Mr Paul Delligatti||View Profile|
|Ms Noelle Dubiansky||View Profile|
|Mr Michael Giannotto||View Profile|
|Mr Bill Hanlon||View Profile|
|Mr Thomas Hefferon||View Profile|
|Mr James Hutchinson||View Profile|
|Mr Michael Isenman||View Profile|
|William Jay||View Profile|
|Mr Paul Jin||View Profile|
|Mr Joshua Klatzkin||View Profile|
|Mr Robert Kurucza||View Profile|
|Mr Kirby Lewis||View Profile|
|Mr Ce Li||View Profile|
|Mr Patrick McCarthy||View Profile|
|Ms Andrea Murino||View Profile|
|Ms Karen Neuman||View Profile|
|Mr Ronald Pabis||View Profile|
|Mr Christopher Palmer||View Profile|
|Mr David Permut||View Profile|
|Mr Mark Raffman||View Profile|
|Mr Jay Schifferli||View Profile|
|Mr Stephen Shahida||View Profile|
|Mr Timothy Shuba||View Profile|
|Mr David Solander||View Profile|
|Ms Marcia Sundeen||View Profile|
|Ms Julie Tibbets||View Profile|
|Kimberly Vargo||View Profile|
|Mr Paul Verbesey||View Profile|
|Mr Mike Whalen||View Profile|
Top Tier Firm Rankings
- Capital markets: equity offerings
- Commercial deals and contracts
- Cyber law (including data privacy and data protection)
- ERISA litigation
- Land use/zoning
- M&A: middle-market ($500m-999m)
- Product liability, mass tort and class actions: consumer products (including tobacco) - defense
- Real estate
- Shareholder activism
- Venture capital and emerging companies
- Corporate governance
- Environment: litigation
- Environment: regulatory
- Financial services litigation
- Healthcare: life sciences
- M&A litigation: defense
- Merger control
- Mutual/registered/ exchange-traded funds
- Patents: licensing
- Patents: litigation (full coverage)
- Private equity funds (including venture capital)
- Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense
- Product liability, mass tort and class actions: toxic tort - defense
- Securities litigation - defense
- Alternative/hedge funds
- Capital markets: debt
- Corporate investigations and white-collar criminal defense
- Employee benefits, executive compensation and retirement plans: design
- Employee benefits, executive compensation and retirement plans: transactional
- Private equity buyouts
- US taxes: non-contentious
- Restructuring (including bankruptcy): corporate